Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma
Background and Objectives As new therapeutic options for multiple myeloma (MM) emerge, identification of biological markers which could predict clinical response to standard treatment with high-dose melphalan (HDM) supported by autologous stem cell transplantation (ASCT) becomes more important.Desig...
Uloženo v:
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Ferrata Storti Foundation
2007-11-01
|
| Edice: | Haematologica |
| On-line přístup: | https://haematologica.org/article/view/4631 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|